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Abstract
Background: We attempt to ascertain if the 3 linked single nucleotide polymorphisms (SNPs) of the Progesterone Receptor
(PR) gene (exon 1: G 1031 C; S344T, exon 4: G 1978 T; L660V and exon 5: C 2310 T; H770H) and the PROGINS insertion in the
intron G, between exons 7 and 8, are associated with Recurrent Spontaneous Abortion (RSA) in the Indian population.
Methodology/Principal Findings: A total of 143 women with RSA and 150 controls were sequenced for all the 8 exons
looking for the above 3 linked SNPs of the PR gene earlier implicated in the RSA, as well as for any new SNPs that may be
possibly found in the Indian population. PROGINS insertion was screened by electrophoresis. We did not find any new
mutations, not observed earlier, in our population. Further, we did not find significant role of the *2 allele (representing the
mutant allele at the three SNP loci) or the T2 allele (PROGINS insertion) in the manifestation of RSA. We also did not find an
LD pattern between each of the 3 SNPs and the PROGINS insertion.
Conclusions/Significance: The results suggest that the PR gene mutations may not play any exclusive role in the
manifestation of RSA, and instead, given significantly higher frequency of the *2 allele among the normal women, we
surmise if it does not really confer a protective role among the Indian populations, albeit further studies are required in the
heterogeneous populations of this region before making any conclusive statement.
Citation: Aruna M, Nagaraja T, Andal S, Tarakeswari S, Sirisha PVS, et al. (2010) Role of Progesterone Receptor Polymorphisms in the Recurrent Spontaneous
Abortions: Indian Case. PLoS ONE 5(1): e8712. doi:10.1371/journal.pone.0008712
Editor: Syed A. Aziz, Health Canada, Canada
Received December 10, 2009; Accepted December 22, 2009; Published January 14, 2010
Copyright:  2010 Aruna et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This project was funded by Indian Statistical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: bmr@isical.ac.in
Introduction
Recurrent Spontaneous Abortions (RSA) is defined as repeated
occurrence of 3 or more miscarriages before 24th week of gestation
[1]. The modern definition, however, is the spontaneous loss of 2
or more consecutive pregnancies before 20 weeks of gestation
[2,3]. Implantation of the embryo is a critical event in pregnancy.
In humans, peri-implantation pregnancy loss contributes to more
than 20% of unexplained infertility. Deficient hormone levels
result in aberrant growth and support of the uterine lining making
it un-ideal for implantation.
Progesterone, a 21 carbon steroid hormone, mainly produced in
the ovaries, placenta, brain and the adrenal glands, is required for
the maintenance of pregnancy and treatment with progesterone
supplementation was observed to prevent abortions. It is mainly
involved in the female menstrual cycle, pregnancy and embryo-
genesis in most mammalian species. It stimulates and regulates
various functions - i) helps in preparing the body for conception
and pregnancy (implantation of the embryo, promoting uterine
growth and suppressing myometrical contractility) [4–6] ii) acts as
an anti-inflammatory agent and regulates the immune response
[7] and iii) regulates estrogen levels and thus prevents endometrial
cancer.
Progesterone receptor (PR) mediates the physiologic effects of
progesterone. The PR gene uses separate promoters and
translational start sites to produce 2 isoforms, PRA and PRB,
the only difference between the two being an additional 165 amino
acids present in the N terminus of PRB. The human progesterone
receptor (hPR) gene was localized to 11q22–q23 [8] and spans
over 90 kb containing eight exons [9]. The open reading frame
corresponds to a protein of 933 amino acids with a molecular
weight of 98,868 Da [10].
Three linked single nucleotide polymorphisms (SNPs) (exon 1:
G 1031 C; S344T, exon 4: G 1978 T; L660V and exon 5: C 2310
T; H770H) in the PR gene were found to be associated with RSA
[11]. The SNP in the exon 1 is reported to be apparently linked to
the SNPs in exons 4 and 5 [11], which are in turn in linkage
disequilibrium (LD) with PROGINS, a 306 base pairs (bp)
insertion of PV/HS-1 Alu subfamily in intron G, between exons 7
and 8 in the codifying region of the hormone binding domain
[11,12,13]. However, contrary to the expectation, Kurz et al. [14]
suggest that PROGINS is not associated with idiopathic RSA.
Thus, only two studies dealt directly with the association of PR
mutations with RSA, one dealing with PROGINS insertion and
other with the 3 SNPs. Polymorphic variants of hPR gene have
been implicated in implantation failure [15,16]. There were also
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studies which did not show association of PR mutations in
implantation failure [17] and preterm birth [18]. To the best of
our knowledge, most of the earlier studies on the role of the PR
mutations in adverse reproductive outcomes were in isolation not
in conjunction with the PROGINS insertion. Further, LD
between the PROGINS and the SNPs has been assumed rather
than empirically tested. Thus, the earlier studies concerning the
role of hPR gene in RSA have been largely inconclusive.
Given that most studies hitherto undertaken were on the
Caucasian populations, it is not known if ethnicity has any role in
the observed pattern of association of PR polymorphisms with
adverse pregnancy outcomes. There were no studies on the role of
these polymorphisms vis-a`-vis RSA in the Asian populations,
especially from India, which is known for its unique population
structure characterized by strictly endogamous castes and tribes.
In view of this, we attempt to ascertain if the 3 linked SNPs of the
hPR gene and the PROGINS insertion are associated with RSA in
the relatively homogenous Indian sample. We also attempt to
explore if we can find any novel SNPs in hPR gene that can be
implicated in RSA.
Results
We did not find any new SNPs in hPR gene, other than the 3
found earlier. The three SNPs found in the PR gene – exon 1: G
1031 C, S344T; exon 4: G 1978 T, L660V; exon 5: C 2310 T,
H770H – co-inherit. The genotype frequencies of the homozy-
gotes for wild type allele (*1), heterozygotes (*1/*2) and
homozygotes for the rarer mutant allele (*2) in the RSA women
were observed to be 127 (88.8%), 15 (10.5%) and 1(0.7%),
respectively, as compared to 122 (81.3%), 25 (16.7%), and 3(2%)
in controls (Figure 1). The genotype frequencies were not
significantly different between RSA and control women
(x2 = 3.44, df = 2, p= 0.18).
The allele frequencies (Table 1) were significantly different
between the cases and the controls in the pooled samples
(x2 = 3.75, df = 1, p= 0.05) as well as between the RSA women
with #3 abortions and controls (x2 = 4.88, df = 1, p = 0.03).
However, this significance is due to an increased frequency of the
*2 allele among the controls, not among the RSA women. Similar
trend was seen when allele frequencies were calculated for the
patients from LFC and FMH and for primary and secondary
aborters separately. Although significant x2 values were observed
to suggest association in the LFC data (x2 = 4.24, df = 1, p = 0.04),
as well as for the primary aborters (x2 = 3.85, df = 1, p= 0.05) the
perceived risk allele (*2), contrary to the expectation, is observed in
higher frequency among the controls, suggesting probably a
protective role of this allele. Further analysis was carried out to
check, if this trend can be statistically validated. Logistic regression
was performed considering a possible protective role for the *2
allele. Although the odds ratio (OR) for the pooled RSA sample
and the controls was only marginally significant (p = 0.056), OR
for the RSA women with 2–3 abortions and the controls was
significant (p = 0.03), suggesting a protective role for the allele
(Table 2).
Statistical power (1-b) of these results was computed using
G*Power 3.1. Given the large sample (2N), the power obtained
was significant at 80% for pooled RSA women (286) and controls
(300) and 87% for RSA women with 2–3 abortions (250) and
controls (300), conferring fair degree of reliability to the findings of
this study.
The analyses of PROGINS Alu insertion revealed genotypic
frequencies of 133 (97.1%) homozygous wild type (T1/T1), 3
(2.2%) heterozygous (T1/T2) and 1 (0.7%) homozygous PRO-
GINS insertion (T2/T2) among the RSA women as compared to
the frequencies of 143 (95.3%), 6 (4%) and 1 (0.7%) among the
controls (Figure 2). The genotype frequencies were not found to be
significantly different between RSA and control women (x2 = 1.05,
df = 2, p= 0.59). Allele frequencies for the T1 and T2 alleles were
observed to be 0.982 and 0.018 and 0.973 and 0.027, respectively
for the RSA and control women. The difference in the allele
frequencies between RSA and control women was not significant
in either the pooled sample or when RSA women with different
number of abortions are separately considered.
Figure 1. Genotype distribution of the PR mutations; (*1) wild
type (G1031, G1978, and C2310) and (*2) mutant allele.
doi:10.1371/journal.pone.0008712.g001
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The mutant alleles considered together at the three SNP sites (*2
allele) and the PROGINS insertion (T2 allele) are reported to be in
LD [11,12,13]. LD analysis was carried out using Haploview
version 4.1 [19] to check if the SNPs in the coding region and the
insertion polymorphism in the intron G were in LD in our sample.
Given the distance between the SNPs in exons 5 and 1 (76kb), our
haploview analysis revealed an LD block (Figure 3) consisting of
only the two SNPs in exons 4 and 5 (separated by 11 kb), even
though the D9 value and the correlation coefficient for all pairs of
comparisons between the three SNPs (i.e., between exons 5 and 4,
exons 5 and 1, exons 4 and 1) is 1. The LD analysis suggests that the
exons 1, 4 and 5 do not show complete LD with the PROGINS.
Discussion
Progesterone receptor mediated effects play a critical role in
female reproduction [5–7,20–22]. We investigated mutations of
the progesterone receptor gene and observed an increased
frequency of the *2 allele in the controls (10.3%) when compared
to the RSA women (5.9%). The frequency of 2.7% of the T2 allele
in the controls in our study is relatively close to the frequency of
5.5% among the normal women from Hyderabad [23]. In our
study, 3 women in the control group were homozygous for the *2
allele, yet they had no abortions suggesting that even the
homozygous mutations are not sufficient to cause RSA. Haploview
analysis suggests that even though the three SNPs show a D9 of 1,
the LD block consists of the SNPs in the exons 4 and 5 only. Based
on our genotyping results, we find that the insertion (T2 allele) is
seen only among the individuals with at least one copy of the *2
allele suggesting a possible association between the *2 allele and
the T2 allele, which is in concordance with the results of
Haploview analysis revealing a partial LD.
We did not find any significant increase in the frequency of
either the *2 allele or the T2 allele among RSA women in our
study of the Indian population and contrary to the expectations,
we find a higher frequency of the *2 allele in the controls.
Therefore, our results based on a relatively larger and more
homogeneous Indian sample suggest that PR gene mutations may
not play a significant role in the manifestation of RSA and,
instead, prompt one to surmise if the *2 allele does not really
confer a protective role among the Indian populations. Our results
are not in agreement with previous reports of associations between
progesterone receptor mutations and adverse reproductive out-
comes including unexplained infertility [15], implantation failure
after IVF/ET [16] and unexplained RSA [11]. Association
between PR polymorphisms and adverse pregnancy outcomes
was both reported [11,15,16] and refuted [14,17,18]. The
discrepancy in the results could be due to multifactorial etiology
as there may be other genes acting in conjunction with the PR,
each with relatively small effect. To be able to detect the relatively
small contribution of PR polymorphisms one would require very
large sample size which has not been the case in most of the
studies. Further, the effect of progesterone receptor is minimal
after 6 weeks of gestation when compared with during the process
of implantation [24]. Most RSA cases that one enrolls are usually
much later than 6 weeks of gestation and therefore, PR mutations
may not be the right candidates. Heterogeneity in study
approaches may also contribute to this inconsistency.
To the best of our knowledge, ours is by far the largest sample as
far as the studies of PR mutations in RSA are concerned. For
example, the studies concerning unexplained infertility [15] and
RSA [11] that yielded positive association with PR mutations were
based on only 26 and 42 cases. Even the studies that yielded
negative results with reference to RSA [14], recurrent implanta-
tion failure [17] and preterm birth [18] were with 125, 66 and 78
cases, respectively, whereas we used 143 cases and 150 controls.
Given the large sample size, the statistical power of our study
should be relatively higher. The 87% of power obtained with
reference to odds ratio probably bears testimony to this, conferring
fair degree of reliability to the findings of our study. We strongly
believe that the ethnic differences in the nature of genetic
predisposition to different complex genetic disorders could also
lead to inconsistency in the pattern of association in our
population, as has also been reported earlier with reference to
other complex disorders in the Indian populations [25]. Thus the
incongruent nature of our findings in the Indian population
concerning the role of PR gene mutations in RSA Vis-a-Vis the
non-Indian populations adds to the ever increasing body of
Table 1. Allele frequencies of the *1 and the *2 alleles.
Allele Freq
PR
mutation
RSA pooled
(n=286)
RSA (n=250)
(2–3 abortions)
RSA (n=36)
($4 abortions)
RSA (n=166)
(LFC)
RSA (n=120)
(FMH)
RSA (n=260)
(1u aborters)
RSA (n=26)
(2u aborters)
Controls
(300)
*1 0.941 0.948 0.889 0.952 0.925 0.942 0.923 0.897
*2 0.059 0.052 0.111 0.048 0.075 0.058 0.077 0.103
Allele Frequencies of the *1 and the *2 alleles in the RSA women (pooled, 2–3 abortions and 4 or more abortions) and the controls, RSA women from LFC and FMH and
in the primary (1u) and secondary (2u) aborters.
RSA women and controls (x2= 3.75, DF = 1, p = 0.05). RSA women (2–3 abortions) and controls (x2= 4.88, DF = 1, p = 0.03). RSA women ($4 abortions) and controls
(x2=0.02, DF = 1, p = 0.88).
RSA women (LFC) and controls (x2= 4.24, DF = 1, p = 0.04). RSA women (FMH) and controls (x2=0.80, DF = 1, p = 0.37). RSA women (LFC) and (FMH) (x2= 0.90, DF= 1,
p = 0.34). RSA women (1u) and controls (x2= 3.85, DF = 1, p = 0.05). RSA women (2u) and controls (x2= 0.18, DF = 1, p = 0.67). RSA women (1u) and (2u) (x2= 0.16, DF= 1,
p = 0.69).
doi:10.1371/journal.pone.0008712.t001
Table 2. Odds ratio for the *2 allele in RSA pooled samples
and in the 2–3 abortions.
B6S.E. p-value OR 95.0% C.I. for OR
Lower Upper
Pooled RSA cases
Vs controls
0.60160.314 0.056 1.824 0.986 3.374
RSA (2–3 abortions)
Vs controls
0.74260.342 0.030 2.101 1.074 4.109
doi:10.1371/journal.pone.0008712.t002
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evidence on the novel patterns of genetic predisposition of Indian
populations to different complex diseases, underlining the
importance of unique Indian population genetic structure.
Despite the crucial role that progesterone plays in the
maintenance of the pregnancy the genetic analysis of PR gene
did not provide formidable evidence towards its association with
RSA, either in the western or Indian populations so as to attach
any prognostic value for RSA. However, since progesterone is
essential for the development of a receptive endometrium, it is
necessary to also consider: progesterone levels (as treatment with
Dydrogesterone or Progesterone helps in prevention of RSA [26–
30]), PR expression levels (reduced levels have been reported in
RSA women [31–33]), its transcription, its relation with estrogen
receptor (ER) and its role in immune modulation along with the
gene mutations in populations of diverse ethnic and geographic
backgrounds before completely ruling out the role of PR in the
manifestation of RSA. On the other hand, our results also suggests
a probable protective role of the *2 allele. Since this study is the
first of its kind in the populations of this region, one should await
results from more populations of diverse ethnic and geographic
backgrounds before making any conclusive statement on the role
of PR in RSA, protective or otherwise.
Materials and Methods
Samples
For the present study, samples were collected from a relatively
homogenous Telugu population from Andhra Pradesh, India.
Women with RSA were recruited from two different hospitals -
Lakshmi Fertility Clinic (LFC) in the suburban Nellore town and
Fernandez Maternity Hospital (FMH) in metropolitan Hyderabad.
These two hospitals not only represent two different socio
economic strata of the patients, but are also separated geograph-
ically by about 500kms. Control samples were collected from
Hyderabad, Nellore and nearby villages so that they broadly
represent matched ethnic and socio-economic backgrounds with
Figure 3. LD plot showing the confidence bounds color scheme
where dark grey suggests strong evidence of LD and light grey
suggests an uninformative status of LD. The analysis reveals that
exons 4 and 5 inherit as an LD Block.
doi:10.1371/journal.pone.0008712.g003
Figure 2. Genotype distribution of PROGINS insertion; (T1)
wild type (no insertion) and (T2) insertion allele.
doi:10.1371/journal.pone.0008712.g002
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that of the cases. This framework facilitates to test if the results are
consistent between the socioeconomically contrasting but genet-
ically somewhat homogenous samples; screening a number of
autosomal STR markers from 27 Telugu populations (castes and
tribes) from different socioeconomic strata, Reddy et al [34]
observed fair degree of homogeneity across the socioeconomic
strata of the populations which form a compact cluster when
compared to the populations of the other regions and linguistic
groups.
Peripheral blood samples (3–5 ml) were collected in EDTA
coated vacutainers from 143 women with RSA of unknown
etiology. Of these 83 were from LFC while remaining 60 were
from FMH. All RSA women, with the mean age of 26 yrs (range
18–37 years of age) and with number of miscarriages ranging from
2 to 9, had regular menstrual cycles and were healthy. Karyotypes
were normal. The women underwent careful clinical examina-
tions, as well as analysis of tissue antibodies and auto-antibodies as
prescribed by their doctors. Women normal for the above tests as
well as for the blood glucose and thyroid stimulating hormone
concentrations were enrolled for the study. A possible infectious
etiology was also ruled out by assessing the reports of the
microbiological cultures of the samples obtained from the cervix
and uterine cavity. A total of 130 women had no previous children
(primary aborters) while 13 had one or two children before the
consecutive miscarriages (secondary aborters). Our control group
consisted of 150 healthy women with no history of abortions and
at least one live born child. Women in the control group were aged
between 18–45 years. Blood samples from the cases as well as the
controls were collected with written informed consent and we had
obtained approval for this study from the Indian Statistical
Institute Review Committee for Protection of Research Risks to
Humans.
Polymerase Chain Reaction and DNA sequencing
DNA was isolated from the above samples following Sambrook
et al., [35] protocol. PCR amplification of all the 8 exons of PR
gene was carried out as per Schweikert et al. [11] and the
PROGINS Alu insertion analysis was carried as per Gomes et al.,
[36]. Reactions were carried out in an ABI Gene Amp PCR
system 9700. Cycle Sequencing of PCR products of the 8 exons
was carried out with either the forward or the reverse primers
using the Big-Dye Terminator ready reaction kit (Perkin Elmer)
depending on the position of the mutation and analyzed on an
ABI 3730 automated DNA Analyzer (Applied Biosystems)
(Figure 4). The PROGINS amplification products were loaded
in a 2% agarose gel, stained with ethidium bromide (1mg/ml), and
electrophoresis was carried out at 100 volts for 30 minutes, in
0.56TAE buffer (Figure 5).
Statistical analysis
Allele frequencies were calculated by gene counting method for the
case and control samples, women with #3 and $4 abortions, RSA
women from LFC and FMH and primary and secondary aborters
Figure 4. Electropherograms of the two SNPs of hPR gene in exon 1 (G1031C) and exon 4 (G1978T).
doi:10.1371/journal.pone.0008712.g004
Figure 5. Gel picture showing bands for homozygotes (T1) allele, heterozygotes (T1/T2), and homozygote (T2) allele run on 2%
agarose. Lane 3, 4, 5, and 6 are heterozygotes, and lane 13 is homozygous for the T2 allele and the remaining are homozygous for the T1 allele.
doi:10.1371/journal.pone.0008712.g005
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separately. x2 analysis and logistic regression were carried out using
SPSS. G*Power was employed to detect the power of the study.
Linkage disequilibrium estimates, for the three SNP loci and the
PROGINS insertion, were calculated using Haploview 4.1 software.
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